| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/17/2010 | EP2152262A2 New heterocyclic derivatives useful for the treatment of cns disorders |
| 02/17/2010 | EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 02/17/2010 | CN201404703Y Distillation kettle used for purifying anti-aging agent RD |
| 02/16/2010 | US7662974 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/16/2010 | US7662821 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2445329C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 02/16/2010 | CA2385081C Carboxylic acid compound and a medicament comprising it |
| 02/11/2010 | WO2010015680A1 Fungicide oxyalkylamide derivatives |
| 02/11/2010 | WO2008044243A3 Novel process for the preparation of statins and their pharmaceutically acceptable salts thereof |
| 02/11/2010 | US20100036149 Method for producing an optically active tetrahydroquinoline |
| 02/11/2010 | US20100035924 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators |
| 02/11/2010 | US20100035909 Novel substituted diaza-spiro-pyridinone derivatives for use in mch-1 mediated diseases |
| 02/11/2010 | US20100035872 Pde10 inhibitors and related compositions and methods |
| 02/10/2010 | EP2151236A1 G-protein-conjugated receptor agonist |
| 02/10/2010 | EP2150533A1 Process for the preparation of optically active ethenylphenyl alcohols |
| 02/10/2010 | EP2150532A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase |
| 02/10/2010 | EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/10/2010 | EP1404659B1 4-aryl quinols and analogs thereof as therapeutic agents |
| 02/10/2010 | CN101646652A Quinoline derivatives and pharmaceutical compositions comprising them for selectin inhibition |
| 02/10/2010 | CN100588655C Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases |
| 02/10/2010 | CN100588649C Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof |
| 02/09/2010 | US7659297 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines |
| 02/09/2010 | US7659286 N-(2-hydroxyethyl)-N-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide |
| 02/09/2010 | CA2484954C 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/09/2010 | CA2315646C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 02/09/2010 | CA2268403C Anthranilic acid derivatives as multi drug resistance modulators |
| 02/09/2010 | CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors |
| 02/09/2010 | CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 02/04/2010 | US20100029945 Process for the purification of Montelukast |
| 02/04/2010 | US20100029716 Novel 1,2,3,4- tetrahydroquinoline derivatives |
| 02/04/2010 | US20100029705 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis |
| 02/04/2010 | US20100029679 Antibacterial quinoline derivatives |
| 02/04/2010 | US20100029677 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml) |
| 02/04/2010 | US20100029623 4-(1-amino-ethyl)-cyclohexylamine derivatives |
| 02/04/2010 | US20100029589 4,5-dihydro-oxazol-2yl derivatives |
| 02/04/2010 | US20100028428 Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol |
| 02/04/2010 | US20100025661 Luminescent material and organic electroluminescent device using the same |
| 02/03/2010 | EP2149558A1 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino-1-arylquinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 02/03/2010 | EP2149557A1 Styrylquinolines, their process of preparation and their therapeutic uses |
| 02/03/2010 | EP2148862A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk |
| 02/03/2010 | CN101641332A Derivatives of the aminated hydroxyquinoline class for treating cancers |
| 02/03/2010 | CN101638385A Novel carbostyril derivative and preparation and application thereof |
| 02/03/2010 | CN101638384A Novel carbostyril compound, preparation and application thereof |
| 02/03/2010 | CN101638383A Quinoline as well as pharmaceutical composition and use thereof |
| 02/03/2010 | CN101638382A Method for preparing 7-chloroquinaldine by utilizing phase-transfer reaction |
| 02/03/2010 | CN101638381A Synthesis method of montelukast sodium intermediate |
| 02/03/2010 | CN100586927C Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 02/02/2010 | US7655801 Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors |
| 02/02/2010 | US7655641 3-(4-{2-[(5-Fluoro-3- methyl-benzo[b]thiophene-2- sulfonyl)-propyl- amino]-ethylsulfanyl}- 2-methyl-phenyl)- propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, hypertension, arteriosclerosis and cardiovascular diseases |
| 02/02/2010 | CA2434162C Reaction method utilizing diaphram type catalyst and apparatus therefor |
| 01/28/2010 | WO2010011570A1 Adamantyl diamide derivatives and uses of same |
| 01/28/2010 | WO2010010149A1 Styrylquinolines, their process of preparation and their therapeutic uses |
| 01/28/2010 | WO2010010148A1 Styrylquinolines, their process of preparation and their therapeutic uses |
| 01/28/2010 | WO2010010147A1 Styrylquinolines, their process of preparation and their therapeutic uses |
| 01/28/2010 | WO2010009814A1 5-[ (3,3,3-trifluoro-2-hydroxy-1-arylpropyl) amino]-1-arylquinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 01/28/2010 | WO2009120774A8 Method of preparing huperzine a and derivatives thereof |
| 01/28/2010 | US20100022777 Process for the Preparation of E-3-[2-(7-Chloro-2-Quinolinyl)Ethenyl]Benzaldehyde |
| 01/28/2010 | US20100022761 Photocleavable linker methods and compositions |
| 01/28/2010 | US20100022587 Derivatives of 2-phenyl-3-hydroxyquinoline-4(1h)-one and methods of their preparation and utilization |
| 01/28/2010 | US20100022585 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 01/28/2010 | US20100022570 Novel microbiocides |
| 01/28/2010 | US20100022547 Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections |
| 01/28/2010 | US20100019657 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/28/2010 | US20100019169 Remote laser interrogation of threat clouds and surfaces |
| 01/28/2010 | CA2728629A1 Adamantyl diamide derivatives and uses of same |
| 01/27/2010 | EP2147913A1 Styrylquinolines, their process of preparation and their therapeutic uses |
| 01/27/2010 | EP2147912A1 Styrylquinolines, their process of preparation and their therapeutic uses |
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/27/2010 | CN101633639A High-purity fleroxacin compound |
| 01/26/2010 | US7652141 Immunosuppressants, analgesics, antiinflammatory agents |
| 01/26/2010 | US7652036 Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors |
| 01/26/2010 | US7652021 (2S)-4,4-difluoro-1-{N-[3-(pyrimidin-2-ylamino)-1-adamantyl]glycyl}pyrrolidine-2-carbonitrile; dipeptidyl peptidase IV enzyme inhibitors; non-insulin dependent diabetes mellitus |
| 01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 01/26/2010 | US7652014 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 01/26/2010 | CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 01/26/2010 | CA2470064C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 01/23/2010 | CA2666208A1 A process for the preparation of e-3-[2-(7-chloro-2-quinolinyl)ethenyl] benzaldehyde, a key intermediate for synthesizing montelukast acid and its salt |
| 01/21/2010 | WO2010009014A2 Antibiotic drug |
| 01/21/2010 | WO2010007964A1 Method for producing 6-aryloxyquinoline derivative and intermediate thereof |
| 01/21/2010 | WO2010007179A1 Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases |
| 01/21/2010 | WO2010007027A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/21/2010 | US20100016597 Method for producing pulverized organic compound particle |
| 01/21/2010 | US20100016380 TNF-alpha production inhibitors |
| 01/21/2010 | US20100016338 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1-arylquinolin-2-ones, a Process for their Production and their Use as Anti-inflammatory Agents |
| 01/21/2010 | CA2730708A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/21/2010 | CA2730331A1 Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases |
| 01/20/2010 | EP2145622A1 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 01/20/2010 | EP2144880A1 Bis(hydroxyquinoline) metal complexes as bleach catalysts |
| 01/20/2010 | EP1555257B1 Process for producing aromatic nitrile compound |
| 01/20/2010 | EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 01/20/2010 | CN100581543C Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 01/19/2010 | US7649094 Reacting diastereomeric mixtures of chiral carboxylic acid compounds with nucleophiles |
| 01/19/2010 | US7649055 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 01/14/2010 | WO2010004198A2 Antineoplastic derivatives, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | WO2009080821A3 Multitarget compounds active at a ppar and cannabinoid receptor |
| 01/14/2010 | US20100010217 Methods for the preparation of imidazole-containing compounds |
| 01/14/2010 | US20100010039 Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 01/14/2010 | US20100009992 Ampk modulators |
| 01/14/2010 | CA2730280A1 5-quinolinone and imidazopyridine compounds and use thereof |